169
Participants
Start Date
June 25, 2019
Primary Completion Date
March 24, 2023
Study Completion Date
March 24, 2023
Zandelisib (ME-401)
Zandelisib (ME-401) 60 mg
Chi-Mei Medical Center, Liouying, Tainan City
Institut Jules Bordet, Brussels
Medical University of Vienna, Vienna
Cliniques Universitaires Saint-Luc, Brussels
Antwerp University Hospital, Edegem
Peninsula and South Eastern Haematology and Oncology Group, Frankston
Kepler Universitatsklinikum GmBH, Linz
The Perth Blood Institute, West Perth
Ente Ospedaliero Cantonale (EOC), Bellinzona
The Catholic University of Korea-Seoul St. Marys Hospital, Seoul
AZ Sint-Jan Brugge-Oostende, Bruges
Southern District Hospital, Dunedin
National Taiwan University Hospital NTUH, Taipei
Memorial Sloan Kettering, New York
Memorial Sloan Kettering, Harrison
Clinical Research Alliance, Lake Success
Memorial Sloan Kettering, Uniondale
Memorial Sloan Kettering, Commack
Stony Brook University, Stony Brook
IRCCS AOU Policlinico San Martino, Genova
Duke Cancer Center, Durham
MD Anderson Cancer Center, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Fundacion Jimenez Diaz, Madrid
Belfast Health and Social Care Trust - Belfast City Hospital, Belfast
Hospital Universitario Quiron Salud Madrid, Madrid
Ospedale DellAngelo Di Mestre Umberto I, Venice
Complejo Hospitalario de Navarra, Pamplona
Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano
H. Lee Moffit Cancer Center, Tampa
Hospital Clinico de Salamanca, Salamanca
Vanderbilt University, Nashville
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Policlinico Sant'Orsola Malpighi, Bologna
China Medical University Hospital, Taichung
Hospital Universitario Virgen Macarena, Seville
Hospital Virgen del Rocio, Seville
Ulsan University Hospital, Ulsan
Cleveland Clinic, Cleveland
Investigative Clinical Research of Indiana LLC, Indianapolis
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori I.R.S.T., Meldola
Infermi Hospital Rimini, Rimini
University of Michigan Medical School, Ann Arbor
Ospedale Santa Maria delle Croci, Ravenna
Universitatsklinikum Munster, Münster
Dong-A University Hospital, Busan
Pusan National University Hospital, Busan
Miguel Servet Hospital, Zaragoza
Hamatologisch-Onkolgische Praxis, Nordheim
University of Wisconsin Carbone Cancer Center, Madison
Marshfield Medical Center, Marshfield
St. Vincent Frontier Cancer Center, Billings
Rush University Medical Center, Chicago
Advocate Health & Hospitals Corporation, Niles
C H de la Cote Basque, Service d'Hematologie, Bayonne
Centre Hospitalier de Mulhouse, Mulhouse
National Cheng Kung University Hospital, Tainan City
Renovatio Clinical, Houston
UOC Oncoematologia, Napoli
Munich Municipal Hospital, Munich
Oncology Institute of Hope and Innovation, Tucson
CHD Vendee, Onco-hematologie, La Roche-sur-Yon
Centre Hospitalier Universitaire (CHU) de Poitiers - Hôpital de la Miletrie, Poitiers
San Juan Oncology, Farmington
The Oncology Institute of Hope and Innovation, Henderson
Universitatsklinikum Ulm, Ulm
Tower Hematology Oncology, Beverly Hills
The Oncology Institute of Hope and Innovation, Downey
Sharp Memorial Hospital, San Diego
Pacific Cancer Medical Center, Inc., Anaheim
Institut Gustave Roussy, Villejuif
Oregon Health and Science University, Portland
Swedish Cancer Institute, Edmonds
Swedish Cancer Institute, Seattle
Medical Oncology Associates PS, Spokane
Cleveland Clinic-Florida, Weston
Dana-Farber Cancer Institute, Boston
Memorial Sloan Kettering, Basking Ridge
Memorial Sloan Kettering, Middletown
Memorial Sloan Kettering, Montvale
Liverpool Hospital, Sydney
Centre Hospitalier du Mans, Le Mans
Klinikum Mutterhaus Feldstr, Trier
Universitatsklinikum Halle, Halle
Universita Cattolica del Sacro Cuore, Roma
IRCCS Regina Elena National Cancer Institute, Rome
Azienda Ospedaliera Santa Maria, Terni
North Shore Hospital, Auckland
Szpital Uniwersytecki nr 2 im., Bydgoszcz
Pratia MCM Krakow, Krakow
ojewodzkie Wielospecjalistyczne Centrum, Lodz
Primary Specialty Oncology, Warsaw
Instytut Hematologii i Transfuzjologii, Warsaw
Dolnoslaskie Centrum Transplantacji Komorkowych z Krajowym Bankiem Dawcow Szpiku, Wroclaw
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitari Mutua Terrasa, Barcelona
ICO-Hospital Duran i Reynals, Barcelona
North Wales Cancer Treatment Centre, Glan Clwyd Hospital, Rhyl
Royal Marsden Hospital, London
Nottingham University Hospital, Nottingham
Royal Cornwall Hospital, Cornwell
e Clatterbridge Cancer Centre, Liverpool
Royal Liverpool University Hospital, Liverpool
Lewisham and Greenwich University Hospital Lewisham, London
St George's Hospital, London
Centre for Haematology, Imperial College London, London
The Christie NHS Foundation Trust, Manchester
Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich
Oxford University Hospitals, Oxford
Royal Hallamshire Hospital, Sheffield
Lead Sponsor
MEI Pharma, Inc.
INDUSTRY